chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer via call center representative and described the occurrence of headache in a 70-year-old female patient who received SHINGRIX. Previously administered products included ZOSTAVAX. Concurrent medical conditions included ophthalmic herpes zoster. On 19th April 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 19th April 2018, several hours after receiving SHINGRIX, the patient experienced headache, weakness, tiredness, chills, fever, facial neuralgia, muscle pain and malaise. On 22nd April 2018, the patient experienced rib pain. In April 2018, the outcome of the facial neuralgia was recovered/resolved. On 22nd April 2018, the outcome of the headache, weakness, tiredness, chills, fever and muscle pain were recovered/resolved. On an unknown date, the outcome of the rib pain was not recovered/not resolved and the outcome of the malaise was unknown. The reporter considered the headache, weakness, tiredness, rib pain, chills, fever, facial neuralgia, muscle pain and malaise to be almost certainly related to SHINGRIX. Additional details were provided as follows: This case was also reported via Merck Service Center. At 11:30, the patient received SHINGRIX on left deltoid. The patient got very ill, went to bed, and could not get up. In the evening of the vaccination day, the patient severe headache, severe neuralgia of the eyes, muscle aches, chills, fever, weak and tiredness. The next day headache was horrific, blinding headache and it couldn't function. Also, chills, fever, weakness and tiredness were worst the next day. Severe neuralgia of eyes was 80 percent resolved by 22nd April 2018. It was fully resolved as of date of report. Three days after receiving SHINGRIX, the patient experienced pain and ache in the lower rib cage area with no rash. The patient also reported shingles in the eyes and was prescribed unknown treatment for this condition. The patient's current condition is unknown since the call got disconnected before all the information could be obtained. The patient stated that the doctor was aware that the patient got the SHINGRIX shot but was not aware that she experienced side effects. The pharmacy was aware that this patient experienced side effects. The lot number and expiration date were unknown by the reporter. No more information was available.
On July 10, 2022 I had an extreme sore throat that hurt worse than anything I had ever experienced. I took a home COVID-19 test on July 11, 2022, that came back positive. I waited to take a second a test that also came back positive. I called my Primary Care Physician and requested a prescription for the PAXLOVID. I started taking the antiviral on July 12, 2022 and quarantined for 5 days and I am feeling better the fatigue is going away.
Reported pain worse than tetanus after vaccine given. Days later, redness/swelling appeared. Slowly improving (right deltoid).
Sore arm at injection site (left only). Treated with analgesics (night-time only, ibuprofen)
After receiving shots developed rash on legs and knot to left thigh. Treatment on 10/7/03: Keflex 250/5 po tid for 7 days. 10/16/03: abscess resolved.
Narrative: COVID infection following COVID vaccine series 02/15, Moderna , dose #1 03/17, Moderna , dose #2 08/19 pt cc: cough diarrhea, fever, headache, rhinorrhea, dyspnea, exposure: unknown 08/20 COVID swab, result: detected 08/20 SARS-COV-2 Variant Sequencing result: pending
Information regarding PREVNAR was received from a healthcare professional regarding a 2-month-old female patient who experienced red swollen lump on lateral thigh that went down to her knee and fever of 102 degrees. At 2 months of age, the patient received a dose on an unspecified date. The patient experienced red swollen lump on lateral thigh that went down to her knee and fever of 102 degrees F. Patient was treated with TYLENOL and recovered for the event of fever after 12 hours.
SEIZURE; FELL ON THE FLOOR; This spontaneous report was received from a consumer and concerned multiple patients. The patients' weights, heights and medical histories were not reported. The patients received COVID-19 vaccine Ad26.CoV2.S (suspension for injection, route of administration not reported, batch number 1808978; expiry date not reported) doses not reported, administered on 02-APR-2021 for prophylactic vaccinations. No concomitant medications were reported. On 02-APR-2021, a total of 24 patients fell on the floor and experienced seizure. The consumer reported that they observed 4 people fall within 15 minutes of vaccination and have seizures, and they also reported that a fire chief had stated to them that an additional 20 patients had also fallen and had seizures. The action taken with COVID-19 vaccine Ad26.CoV2.S was not applicable. The outcomes of the seizures and falls were not reported. This report was serious (other medically important condition).; Sender's Comments: v0 This report received from a consumer who reported seeing 4 people fell within 15 minutes and had "seizures" after receiving Janssen COVID-19 Vaccine Ad26.COV2 and also hearing that of an additional 20 patients who fell and had "seizures" from a fire chief.  Medical history, concomitant medications, and details of the events were not reported. This case has insufficient information to make a meaningful medical assessment. The case will be assessed further when additional information is received.
Swelling and warmth over right deltoid where PREVNAR 13 vaccine was given yesterday.
The medication that was supposed to be administered was the Pfizer bivalent vaccine but the monovalent vaccine was accidentally administered.
Received shot at 5 weeks pregnant. During the time the heart is being formed in the fetus. Fetus was formed with severe heart defects.
FELT LIGHTHEADED. OBSERVED, HE THEN REPORTED FEELING BACK TO NORMAL
10/28/10 8pm Reported sneezing started. 10/29/10 Woke up with sore throat. Respiratory illness coming on. 10/31/10 Sore throat subsided. Still experiencing congestion, runny nose. 11/2/10 Still experiencing congestion, runny nose, "feeling feverish".
Tongue throat tingled; Tongue throat tingled; This is a spontaneous report received from a contactable consumer (patient). A 55-year-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular, administered in left arm on 22Apr2021 15:45 (Batch/Lot Number: EW0175) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took the dose 1 of bnt162b2 (Batch/Lot number: ER8733) intramuscular in left arm on 30Mar2021 01:15 (at age of 35 years old, as reported) for COVID-19 immunization. On an unspecified date, the patient experienced tongue throat tingled. The doctor talked to the patient, took Benadryl (as reported). The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a nurse referring to a patient of unknown age or gender.  The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On 26-JAN-2018, the patient was vaccinated with PROQUAD Albumin status of rHA (recombinant human albumin) for lot # N021728, expiration date on 06-FEB-2019, in addition to M-M-R II lot #M045391 and expiration date on 14-NOV-2018; subcutaneously for prophylaxis (strength, doses and anatomical locations were not reported). No adverse effect was reported and no additional information was provided. Sterile diluent (lot # M034911 and expiration date on 05-MAY-2019) was used.
shot was painful pt reported shoulder kept hurting more until it became painful to use arm;pt reports it is still paining
Patient has a large hard lump/ nodule the size of a quarter 6 days after the vaccine was administered.
Erythema, edema.  CBC-6200 WBC with 65/35% L/M.  BENADRYL over the counter as directed.
her Left arm shoulder pain.; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer(patient) reported that a female patient of an unspecified age receive the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from 30Jan2021 on left arm at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. After the dose, patient was injected with cortisone for her left arm shoulder pain. She is asking if it will lessen the effects of the vaccine.  Information on the lot/batch number has been requested.
Body aches, headache, slight fever, fatigue lasting....... 24 hours 3 days after injection lower back ache started lasting  about 36  hours
I developed a large ring around my injection site on 2/7/21 12 days after my first covid moderna vaccine dose. It was exactly 12 hours after I administered my monthly ajovy injection for migraine treatment ( a monoclonal antibody medication ) in my right arm. My vaccine site is my left arm. Before this time, I had little to no reaction to the vaccine. My arm was a little red at the injection site on day 2 but swiftly went away. The large red rash type reaction was hot  it was not painful. It began to radiate out like a bulls eye rash would look after Lyme infection. It was a bullseye ring rash for about 4 days and then subsided. I felt tired during that time but no other symptoms like fever.
Small red rash around injection site, approximately 24 hour post injection. No itching/pain. Normal side effect.
Moderna Covid-19 Vaccine Had SEVERE abdominal cramping  3hrs after vaccine injection, with vomiting x3, diarrhea for 3 hrs, then every 2-3 hrs passing small amt. blood (2-3 Tablespoons) rectally x4.  Cramping continued next day, and milder today.  Stayed on clear liquid diet since symptoms began.  Saw healthcare provider 3/17/21.  Prescribed hydrocortisone suppositories.  Stop aspirin, losiniprol, and Janumet until symptoms subside and able to eat.  Instructions to go to ER if unbearable cramping or passing larger amt. of blood with BMs, or fever >100.
12/30/21 presents to ED for "shortness of breath". PMHx of "A-Fib on Coumadin, CAD, LE DVT, CHF, GERD, HLD, and Lymphoma"
pt recvd vax & fever up to 104; 6NOV93 through 9NOV93 hospitalized 9NOV93;
stroke after each shot; This case was reported by a consumer via interactive digital media and described the occurrence of stroke in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of cerebrovascular accident (1st dose received on an unknown date, refer case US2021AMR193810).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced stroke (serious criteria GSK medically significant). Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the stroke was unknown.   It was unknown if the reporter considered the stroke to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, he/she know the patient who took the Shingle shot and experienced stroke after the shot.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR193810:same patient/same reporter
Tinnitus got considerably worse after the second dose; This is a spontaneous report from a contactable healthcare professional, the patient. A 64-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 30Apr2021 at 09:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (HBP), statin (as reported), allergy to pen (pencillin) and sulfa and ongoing tinnitus. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received unspecified concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 at 09:00, as a single dose for COVID-19 immunisation.  The patient previously received codeine (MANUFACTURER UNKNOWN) and experienced drug allergy.  On an unknown date in Apr2021, the patient experienced tinnitus which got considerably worse after the second dose. The patient went to primary and ear nose throat (ENT) and mentioned about it and primary thought could be an effect from vaccine. ENT said ears looked fine and suggested hearing test however the patient refused at that time. The ringing in ears had not lessened any and was very bothersome. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus got considerably worse after the second dose was not resolved at the time of the report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Guillain Barre Syndrome; Fatigue; nausea; decreases and increases in blood pressure; weakness; This case was reported by a physician via call center representative and described the occurrence of guillain barre syndrome in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, couple of weeks after receiving Shingrix, the patient experienced guillain barre syndrome (serious criteria hospitalization and GSK medically significant), fatigue (serious criteria hospitalization), nausea (serious criteria hospitalization), change in blood pressure (serious criteria hospitalization) and weakness (serious criteria hospitalization). On an unknown date, the outcome of the guillain barre syndrome, fatigue, nausea, change in blood pressure and weakness were resolved with sequelae.   It was unknown if the reporter considered the guillain barre syndrome, fatigue, nausea, change in blood pressure and weakness to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received Shingrix and reporter was not sure whether it was 1st or 2nd dose of vaccine. Few weeks after receiving the vaccine, patient was diagnosed with Guillain Barre Syndrome. The patient also experienced weakness, fatigue, nausea and decreased and increased in blood pressure (blood pressure fluctuation). The patient went to the emergency room  and also went to a walk in clinic. He was hospitalized from 12th January 2019 to 12th November 2019 and then went to a rehabilitation center for some time. The patient was at home at the time of reporting.
Panic Attacks during the night/ heart palpitations, anxiety  Cardiac monitoring, labs, EKG, ECHO, Chest X-ray, Antianxiety med (Zoloft) prescribed by the physician
symptoms: Hot, flush, scratchy throat  Benadryl 50mg IM Relieved symptoms
"Dizzy spells, loss of coordination had about a week after shot.  Had an I.V. for possible dehydration.  Had seizures and temp when a baby to a DTP vaccine." Per patient' written statement.
Flu-like symptoms; feeling bad; This case was reported by a consumer and described the occurrence of influenza-like symptoms in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In March 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced influenza-like symptoms and feeling bad. On an unknown date, the outcome of the influenza-like symptoms and feeling bad were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms and feeling bad to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported but could be 71 or 72 years. The patient experienced flu-like symptoms and feeling bad after 1st dose of Shingrix vaccination. For tolerance with 2nd dose refer case US2021AMR002678. The reporter consented to follow up; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR002678:same reporter
Pt received TDap along with MCV. MCV was first injection, then MCV. Clinical person stuck the finger for POC hgb, left the room, returned and patient was faint, clammy, c/o stomach was cramping up, stated that he was nauseous. Venipuncture was attempted for labs, that was stopped mid draw. Given emesis basin, water, popsicle in office. Patient was reclined, MD brought in to observe for 15 minutes. After observed, patient was released with father.
Have not received any treatments. Dr. Advised to get some rest and take tylenol. Which I have been doing g since I received the shot.
Site: Pain at Injection Site-Severe, Systemic: Joint Pain-Severe, Additional Details: Joint Inflammation, tendonitis, elevated creatine protein. The Dr  prescribed celebrex
felt like his kidneys were gonna stop functioning; This serious case was reported by a consumer via interactive digital media and described the occurrence of renal function abnormal in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced renal function abnormal (Verbatim: felt like his kidneys were gonna stop functioning) (serious criteria GSK medically significant). The outcome of the renal function abnormal was not reported.   It was unknown if the reporter considered the renal function abnormal to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the renal function abnormal to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt date: 02-Mar-2023 This case was reported by patient's friend via interactive digital media. The reaction the reports friend got from the 2 regimens Scared me because he felt like his kidneys were gonna stop functioning and he almost went to the emergency room. Follow-up would not possible as no contact details were available.
Patient was administered improperly stored PROQUAD on unknown, previous date; No additional AE reported; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concomitant therapies, and concurrent conditions were nor provided.  On an unknown date, the patient was vaccinated with an improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant Human albumin (rHA) (PROQUAD) subcutaneous injection, lot # W017567, expiration date 29-NOV-2023 (dose, dose number, strength, route of administration, and anatomical location were nor provided) for prophylaxis (product storage error). On 19-AUG-2022, the administered measles, mumps, rubella and varicella (oka-merck) virus vaccine live, rHA (PROQUAD) underwent temperature excursion of 7.7 Fahrenheit (F) degrees for 10 minutes. Previous temperature excursions included: 7.3 F degrees, from 6 F degrees to 14 F degrees for 10 minutes on 09-AUG-2022, 7.0 F degrees, from 6 F degrees to 14 F degrees for 9 minutes on 08-AUG-2022, 7.2 F degrees, from 6 F degrees to 14 F degrees for 9 minutes on 04-AUG-2022, and 7.5 F degrees, from 6 F degrees to 14 F degrees for 10 minutes on 03-AUG-2022. No additional adverse event was reported (no adverse event).  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2209USA000852:
red, non-itchy rashes over his chest and arms; fever; chills; fatigue; This spontaneous case was reported by a physician and describes the occurrence of RASH (red, non-itchy rashes over his chest and arms), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 025J20-2A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue). On 17-Feb-2021, the patient experienced RASH (red, non-itchy rashes over his chest and arms). On 17-Feb-2021, PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) had resolved. On 20-Feb-2021, RASH (red, non-itchy rashes over his chest and arms) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.     No concomitant medications were reported.  Treatment information was not provided.   This case was linked.
Patient got vaccinated for Pfizer 1st dose. Patient said she was feeling electric shock at the end of the 20 minutes wait time. She was breathing normal with no signs and symptoms of severe allergic reaction. I called 911 and watched her until paramedic came and she was transferred to ED.  I called her in the evening that day. She said she was feeling better. She said no one examined her in ED and she came back home.
@ 12:19 initial vitals were taken prior to vaccine due to patient having to go to ER from primer vaccine.  @12:36 He reported dizziness, BP sitting  BP 110/65 P 90 O2 97%. Standing BP 110/80. Pt denied itching or discomfort.  @1251 patient had emesis X3 @1259 BP 117/70, O2 97% P 87 @ 1315 pt reported feeling better, his PCP was notified and requested to get prescription for Zofran.
Tiredness; headache; muscle pain; joint pain; not feeling well; nausea; Stiffness in neck, shoulders and upper back. Having a hard time turning neck; This is a spontaneous report from a contactable consumer (patient). A 64-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EW0778, Expiry Date: Not Reported), via an unspecified route, administered in Left Arm on 27May2021 (at the age of 64-year-old) at 12:30 as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccine within four weeks. The patient medical history included breast cancer, diabetes mellitus. The patient's concomitant medications were not reported. The patient was allergic to codeine and contrast dye. On 29May2021 (Saturday) at 2.30, the patient experienced tiredness, headache, muscle pain, joint pain, not feeling well, nausea, stiffness in neck, shoulders, and upper back, having a hard time turning neck and patient still having these symptoms 5 days later. Patient  don't feel any relief in my neck or back. The patient did not receive any treatment for the reported event. The patient was not diagnosed with covid prior vaccination. The patient was not tested for covid post vaccination. Outcome of the events was Not Recovered.  No follow-up attempts are needed. No further information is expected
Patient undiluted dose of Pfzier vaccine. The 6 dose vial was not diluted, and the full contects of the undiluted dose was administered IM in her right deltoid.  No adverse reaction experienced immediately following administration.  Follow up report from patient today (6/4/21) at noon and at 7:28 Pm is that she feels fine and is not experiencing any adverse reaction.
Varicella vaccine breakthrough.  Diagnosed with Varicella on 02/20/2006.  8 papular lesions, no fever.  Rash started 02/19/2006.  Rash on torso and extremities.